Bo Claes, auteur op YUN

What if supporting the ear microbiome could change how we approach ear care in dogs?

What if supporting the ear microbiome could change how we approach ear care in dogs? 19/05/2026 | Probiotherapy | 5 min read “Antimicrobial resistance remains a growing global challenge, including in veterinary medicine.” Ear infections are one of the most common reasons dog owners visit the vet. And they often keep coming back. This has […]

What if supporting the ear microbiome could change how we approach ear care in dogs? Read More »

Antimicrobial resistance is accelerating. Dermatology needs a new model.

Probiotherapy

Antimicrobial resistance is accelerating. Dermatology needs a new model. 19/05/2026 | Probiotherapy | 5 min read “The future of skin health is not more destruction. It is precision with preservation.” By 2050, antimicrobial resistance (AMR) is projected to kill more people than cancer. Nearly 40 million direct deaths worldwide, with annual deaths rising sharply if

Antimicrobial resistance is accelerating. Dermatology needs a new model. Read More »

Understanding the vaginal microbiome: why balance matters for skin health

VGN

Understanding the vaginal microbiome: why balance matters for skin health 3/02/2026 | Probiotherapy | 6 min read “In a healthy vaginal microbiome, Lactobacilli dominate not by coincidence, but by function.” The vaginal microbiome is a highly specialised ecosystem that plays a fundamental role in intimate skin health. When this ecosystem is balanced, it acts as

Understanding the vaginal microbiome: why balance matters for skin health Read More »

We believe in the bacterial revolution – Interview with CEO Tom Verlinden

Probiotherapy

We believe in the bacterial revolution 3/02/2026 | Probiotherapy | 6 min read “Within eighteen months, our YUN products will reach two billion people worldwide,” says our founder & CEO Tom Verlinden. With six unique, globally recognized patent families, the Belgian Niel-based biotech company YUN is the only enterprise in the world to have sparked

We believe in the bacterial revolution – Interview with CEO Tom Verlinden Read More »